RV
Rachel Vatnsdal JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
10
Avg Return
Past Year
Past Year
8.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
60%
Neutral
30%
Negative
10%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Materials
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Materials
Specialty Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $105 |
21%
upside
| 2 | – |
–
| 3 Feb ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $20 |
41%
upside
| 2 | +18% |
0
%
| 6 Nov ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $76 |
2%
downside
| 1 | +13% |
0
%
| 7 Aug ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $14 |
77%
upside
| 1 | -31% |
0
%
| 4 Aug ‘25 8 months ago |
|
|
|
Overweight
Initiated
| $31 |
53%
upside
| 1 | -28% |
0
%
| 14 Jul ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $9 |
59%
downside
| 1 | – |
–
| 9 May ‘25 11 months ago |
|
|
|
Underweight
Maintained
| $33 |
46%
downside
| 1 | -26% |
0
%
| 6 May ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $190 |
62%
upside
| 1 | -20% |
0
%
| 29 Apr ‘25 1 year ago |
|